BIORON and GENAPSYS start with Business Corporation in Germany


With February 2021 BIORON will represent GENAPSYS in Germany and will offer a new sequencing system and technology for a broad scale of customers in academia and industry. The new cooperation gives ideal synergy effects between BIORONs molecular biological tools and the unique sequencing technology of GENAPSYS.

Especially the high demand in Germany for biological surveillance and the increased demand for genetic data information, offers sequencing labs new opportunities. The GENAPSYS system generates DNA sequence information based on a new method and technology. GENAPSYS developed a novel electrical-based platform capable of accurately detecting single base incorporations. The semiconductor chip-based detection modality allows the system to be compact, scalable, and affordable. In combination with smart sample preparation tools of BIORON for the isolation, amplification, fragmentation and labeling of the targeted probes, we can now offer an end-to-end solution to individual research labs for many sequencing applications.

With this precise and cost-effective sequencing technology available more research labs and life science companies can be enabled for the SARS-Cov-2 pandemic control and monitoring for a better understanding of the pandemic and the virus itself. The UK-NHS labs analyze 20-times more clinical Corona sample in comparison to the German virus reference labs due to the missing appropriate systems and resources. GENAPSYS offers a complete process for the necessary routine monitoring of the virus variants. More information at

Several research labs in Europe have requested and installed the GENAPSYS technology in 2020 and the chip-based DNA sequencing process shows several advantages. The integration of standardized sample preparation, sequencing and data interpretation offers a great complement to existing sequencing methods and establishes a new standard. The turnaround time and operating cost are very competitive compared to other commercial solutions. The sample handling is compatible with the standard lab procedures and the systems requires less space and maintenance compared to other NGS systems.

Dr. Armin Winands / GENAPSYS Europe and Simon Koerpert / BIORON GmbH are responsible for the cooperation and distribution of both Life Science portfolios and the synergy effect will offer a professional service and support for all existing and new customers. Now both companies bring in  the right tools with the best timing.

The BIORON-GENAPSYS cooperation is very important and the chip technology of GENAPSYS is similar unique like the SD-Polymerase of BIORON. It is special designed enzyme for the DNA amplification. This key enzyme is already as standard enzyme for Single Cell Whole Genome Amplification, One Step Whole Genome Amplification, DNA Fragmentation, DNA-Library generation and Liquid Biopsy with the Cell-free Extraction kit.

This means, beside the current application for the virus variant monitoring, both product portfolios can be used for Cancer Research, PID-Diagnostics, HLA-Analytics and individual precision medicine of the future.

GENAPSYS, Inc. is a private company headquartered in Redwood City, California. The company was founded by Dr. Hesaam Esfandyarpour. He and his team developed several novel technologies for DNA sequencing and protein detection at Stanford Genome Technology Center, prior to founding GenapSys in 2010. With a strong background in electrical engineering (MS, PhD Electrical Engineering, Stanford), Dr. Esfandyarpour was able to conceive and demonstrate a novel and far higher efficiency method for DNA sequencing. Instead of optical-based technologies traditionally used in the industry, the GENAPSYS system centers around a pure electronic chip, with a simple, elegant, accurate and low-cost solution. Since incorporation, GENAPSYS has built a stellar multidisciplinary team and set up headquarters in Redwood City, CA.

BIORON GmbH is a private company with headquarter in southwest Germany – Roemerberg and is a premium manufacturer and worldwide-acting business partner for molecular biological and diagnostic products since 2002. The main focus is on different specific tools for a wide variety of PCR applications and BIORON has a high quality and service commitment to achieve each of our customer requirements in a direct and short approach. Since 2020 the additional focus is also on Next Generation Sequencing and BIORON offers a collection of tools and assays to improve sample handling for preparation in accordance with new sequencing technologies.

Interested in new and effective sequencing methods ?

Simon Körpert
Senior Director International Sales

In den Rauhweiden 20
67354 Roemerberg

+49 6232 298 45 07

Dr. Armin Winands
Head of Sales & Support EMEA

200 Cardinal Way, Redwood City
CA 94063
United States of America

+49 172 8678 848